John Oliver tackles America's opioid and heroin crisis, and boy is he mad at Big Pharma
"I would like to talk to you about drugs," John Oliver said on Sunday's Last Week Tonight, but not in some 1960s "reefer madness" way. "Unfortunately, America is now in the midst of a new drug crisis, and it seems that no one is safe from it," he said. That would be the "epidemic of addiction to opioids, like heroin and prescription painkillers," he said, and it's a serious one: As of 2015, an estimated 2.6 million Americans were addicted to these drugs, and some 30,000 Americans die from overdoses each year from heroin and prescription opioids.
Oliver focused on the prescription variety, the chemical cousins of heroin that some 75 percent of U.S. heroin addicts started their addiction with. Now, according to the U.S. surgeon general, some 250 million opioid prescriptions are written each year, equal to one for each adult. It wasn't always this way — as recently as the early 1990s, doctors were "excessively wary" about prescribing these powerful, addictive drugs, Oliver said. And it wasn't just Big Pharma — patient advocates argued that excessive fear of opioids was causing injured and dying people too much pain. But when Perdue — maker of OxyContin — and other drug companies got involved in the late 1990s, he said, all hell broke loose.
After discussing Perdue's shady marketing and downplaying of addiction risk, Oliver said we "may be glad to hear that in 2007 they admitted some responsibility," paying out $634 million. "But at a certain point, the question has to become less 'What did we do wrong?' and more 'What do we do now?'" Oliver said. "There is no one simple answer here." We need to be more careful about prescribing opioids and make alternative treatments more widely available, he said, but "not all opioid addicts will respond to the same treatments, and not all people in pain will find relief from alternative therapies. This is going to take a massive effort and a significant investment — it won't be cheap, it won't be quick, and it won't be easy. And it is hard not to be angry at the drug companies, like Purdue, whose promise of cheap, quick, easy pain solution helped put us in this f---ing mess." Watch below, and be warned, that last F-bomb isn't bleeped out. Peter Weber
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published
-
Immigration helped the US economy outpace peers
speed read The U.S. economy grew at an annualized rate of 3.2% last quarter
By Peter Weber, The Week US Published
-
4-day workweek gets boost from UK study
Speed Read Following a six-month trial, the majority of participating British companies are still using the truncated schedule
By Peter Weber, The Week US Published
-
US sues to block Kroger-Albertsons merger
Speed Read The Federal Trade Commission sued to block the $24.6 billion merger between the grocery giants
By Peter Weber, The Week US Published
-
Nvidia sees historic stock rise on AI chips success
Speed Read U.S. chipmaker Nvidia achieved the biggest one-day increase in value of any company in history
By Peter Weber, The Week US Published
-
New York may seize Trump's assets for $450M penalty
Speed Read The former president likely owes $600 million from two civil judgments in New York
By Peter Weber, The Week US Published
-
Capital One to buy Discover for $35B
Speed Read The deal, if cleared by regulators, would create the biggest credit card lender in the country
By Peter Weber, The Week US Published